Home > PE Ratio > LASA SUPERGENERICS

LASA SUPERGENERICS
PE (Price/Earnings) Ratio

The Current P/E Ratio of LASA SUPERGENERICS is -5.63.

Share Price ₹25.5Jan 14,2025
Market Cap ₹127.9 Cr
Earnings-TTM₹-22.7 CrTTM-Standalone Results
Price/Earnings-5.63xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for LASA SUPERGENERICS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of LASA SUPERGENERICS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of LASA SUPERGENERICS is calculated as :

Current Market Cap [ ₹127.9 Cr] as on Jan 14,2025

(/) Earnings [ ₹-22.7 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ -5.63x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for LASA SUPERGENERICS , the investors are currently willing to pay -5.63 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LASA SUPERGENERICS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of LASA SUPERGENERICS over the last five years.

Historical PE (Price/Earnings) ratio chart of LASA SUPERGENERICS


PE Ratio Performance Analysis for LASA SUPERGENERICS

- LASA SUPERGENERICS 's latest p/e ratio is -5.63x.

- LASA SUPERGENERICS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.51x.

- LASA SUPERGENERICS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LASA SUPERGENERICS 's p/e ratio peaked in Mar2020 at 31.83x.

- LASA SUPERGENERICS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does LASA SUPERGENERICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
LASA SUPERGENERICS -22.72-5.63127.9
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.11424,382.0
CIPLA LTD4,485.2226.07116,943.0
DR REDDYS LABORATORIES LTD5,406.8020.64111,588.0
ZYDUS LIFESCIENCES LTD4,298.9023.43100,704.0
DIVIS LABORATORIES LTD1,836.0086.72159,224.0
MANKIND PHARMA LTD2,124.8651.87110,215.0
TORRENT PHARMACEUTICALS LTD1,802.0061.12110,142.0
LUPIN LTD2,651.9437.0898,330.0
AUROBINDO PHARMA LTD3,598.8318.9668,238.4
ABBOTT INDIA LTD1,284.6646.7460,041.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LASA SUPERGENERICS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -5.63x
Max industry PE 86.72x
Median industry PE 37.08x
Average industry PE 36.83x



You may also like the below Video Courses